跳转至内容
Merck
CN

1343550

USP

Iodixanol Related Compound D

United States Pharmacopeia (USP) Reference Standard

别名:

Iopentol, 5-[Acetyl(2-hydroxy-3-methylpropyl)amino]-N,N′-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C20H28I3N3O9
化学文摘社编号:
分子量:
835.16
MDL number:
UNSPSC Code:
41116107
NACRES:
NA.24
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

Iodixanol Related Compound D, United States Pharmacopeia (USP) Reference Standard

SMILES string

Ic1c(c(c(c(c1C(=O)NCC(O)CO)I)C(=O)NCC(O)CO)I)N(CC(O)COC)C(=O)C

InChI

1S/C20H28I3N3O9/c1-9(29)26(5-12(32)8-35-2)18-16(22)13(19(33)24-3-10(30)6-27)15(21)14(17(18)23)20(34)25-4-11(31)7-28/h10-12,27-28,30-32H,3-8H2,1-2H3,(H,24,33)(H,25,34)

InChI key

IUNJANQVIJDFTQ-UHFFFAOYSA-N

grade

pharmaceutical primary standard

API family

iodixanol

manufacturer/tradename

USP

application(s)

pharmaceutical (small molecule)

format

neat

正在寻找类似产品? 访问 产品对比指南

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Application

Iodixanol Related Compound D USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.
Also, for use with USP monographs such as:
  • Iodixanol Injection
  • Iodixanol

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Other Notes

Sales restrictions may apply.

存储类别

11 - Combustible Solids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

S Spitzer et al.
Clinical hemorheology and microcirculation, 20(1), 49-55 (2001-02-24)
PURPOSE, MATERIAL AND METHODS: The aim of this study was to investigate the influence of direct intraarterial application of the contrast agents Iodixanol-270 and Iopentol-150 on the capillary perfusion. This was accomplished through continuous recording of the capillary perfusion in
S G Spitzer et al.
Acta radiologica (Stockholm, Sweden : 1987), 43(6), 617-622 (2002-12-18)
To investigate the influence of two non-ionic radiographic contrast media with different osmolality on thrombocytic function and the plasmatic coagulation system. The study was carried out as a randomised, prospective, comparative study with two contrast media in a heart catheter
Amina Abdelmoumene et al.
European radiology, 15(9), 1881-1887 (2005-05-04)
This study compared different acquisition protocols performance to detect small liver metastases (<2 cm). Thirty consecutive patients with histologically proven hepatic metastases were explored by MDCT at the liver equilibrium phase by four successive acquisitions. We compared the following protocols
Markus Selzner et al.
Annals of surgery, 240(6), 1027-1034 (2004-12-01)
To compare the diagnostic value of contrast-enhanced CT (ceCT) and 2-[18-F]-fluoro-2-deoxyglucose-PET/CT in patients with metastatic colorectal cancer to the liver. Despite preoperative evaluation with ceCT, the tumor load in patients with metastatic colorectal cancer to the liver is often underestimated.
Severe Stevens-Johnson syndrome induced by contrast medium iopentol (Imagopaque).
E Laffitte et al.
The British journal of dermatology, 150(2), 376-378 (2004-03-05)

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持